Recce Pharmaceuticals Ltd
OTC:RECEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recce Pharmaceuticals Ltd
OTC:RECEF
|
AU |
|
M
|
Minesto AB
DUS:7MN
|
SE |
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
Perma-Pipe International Holdings Inc
F:MF3
|
US |
|
Diagnostic Medical Systems SA
F:DMS1
|
FR |
|
C
|
clearvise AG
DUS:ABO
|
DE |
|
Origin Materials Inc
NASDAQ:ORGN
|
US |
|
M
|
Metcash Ltd
SWB:MG9
|
AU |
|
A
|
AGL Energy Ltd
OTC:AGLNF
|
AU |
|
China Youzan Ltd
F:YSZ
|
HK |
|
Pieris Pharmaceuticals Inc
NASDAQ:PVLA
|
US |
|
A2A SpA
OTC:AEMMF
|
IT |
|
E
|
Endesa SA
XHAM:ENA
|
ES |
|
C
|
CSW Industrials Inc
F:UCI
|
US |
|
Vivoryon Therapeutics NV
LSE:0R3M
|
DE |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
S
|
Sun Life Financial Inc
F:LIE
|
CA |
|
P
|
Power Corporation of Canada
OTC:PWCDF
|
CA |
|
C
|
China Literature Ltd
F:C2X
|
CN |
|
B
|
Bank of Communications Co Ltd
SWB:C4C
|
CN |
Bankruptcy Probability
Recce Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Recce Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
164.8m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
556.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
249.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Recce Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Recce Pharmaceuticals Ltd has total debt of 8.7m AUD. This includes both short-term (0 AUD) and long-term (8.7m AUD) debt.
You can find a full breakdown on its Balance Sheet.
